Literature DB >> 18065788

Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.

Michal L Melamed1, Joseph A Eustace, Laura C Plantinga, Bernard G Jaar, Nancy E Fink, Rulan S Parekh, Josef Coresh, Zan Yang, Tom Cantor, Neil R Powe.   

Abstract

BACKGROUND: There has been controversy about the utility of new third-generation parathyroid hormone (PTH) assays measuring only 1-84 PTH, with few large studies comparing second- and third-generation PTH measurements in patients with ESRD.
METHODS: We measured 1-84 PTH ('biointact' or 'whole' PTH) and total PTH ('intact' PTH) in a national cohort of 515 incident dialysis patients from banked frozen EDTA plasma (median follow-up, 35 months) and examined the accuracy of estimating 1-84 PTH from total PTH and the associations of these levels with patient characteristics and mortality.
RESULTS: The 1-84 PTH and total PTH levels were closely correlated. Higher 1-84 PTH was associated with African-American race and higher serum phosphate and lower calcium levels. The percentage of total PTH represented by 1-84 PTH was, on average, 53%, but with a wide range (25-89%). Calculating 1-84 PTH from total PTH using a proposed standard conversion factor (54%) led to misclassification of 8% of the population compared with measured 1-84 PTH. In a multivariate Cox proportional hazards model for all-cause mortality, a 1-84 PTH value >160 pg/ml was associated with increased risk of mortality (HR = 1.62, 95% CI, 1.03-2.54) compared to a level of 80-160 pg/ml. Elevated total PTH, 7-84 PTH and the 1-84 PTH/7-84 PTH ratio were not significantly associated with mortality.
CONCLUSIONS: The 1-84 PTH and total PTH are highly correlated. Elevated 1-84 PTH was significantly associated with increased mortality, whereas total PTH did not reach statistical significance. Thus, although in other respect they are similar, there may be utility in measuring 1-84 PTH for its associations with mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18065788     DOI: 10.1093/ndt/gfm849

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

Review 1.  Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.

Authors:  Kamyar Kalantar-Zadeh; Anuja Shah; Uyen Duong; Rulin C Hechter; Ramanath Dukkipati; Csaba P Kovesdy
Journal:  Kidney Int Suppl       Date:  2010-08       Impact factor: 10.545

2.  Variation in oral calcitriol response in patients with stages 3-4 CKD.

Authors:  Abigail B Shoben; Gregory Levin; Ian H de Boer; Catherine Yeung; Suzanne Watnick; Ernie Ayers; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2012-01-29       Impact factor: 8.860

3.  Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure.

Authors:  D Gruson; T Lepoutre; S A Ahn; J M Ketelslegers; M F Rousseau
Journal:  J Endocrinol Invest       Date:  2012-02-28       Impact factor: 4.256

4.  Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients.

Authors:  Fumihiko Koiwa; Daisuke Komukai; Makoto Hirose; Ashio Yoshimura; Ryoichi Ando; Toshifumi Sakaguchi; Yasuhiro Komatsu; Toshio Shinoda; Daijo Inaguma; Nobuhiko Joki; Hidemi Nishida; Masato Ikeda; Takashi Shigematsu
Journal:  Clin Exp Nephrol       Date:  2011-09-14       Impact factor: 2.801

5.  Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.

Authors:  Emanuel Zitt; Christine Jäger; Alexander R Rosenkranz; Manfred Eigner; Katharina Kodras; Josef Kovarik; Helmut Graf; Frank Pétavy; Sabine Horn; Bruno Watschinger
Journal:  Wien Klin Wochenschr       Date:  2011-01-21       Impact factor: 1.704

6.  Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.

Authors:  Ramanath Dukkipati; Csaba P Kovesdy; Sara Colman; Matthew J Budoff; Allen R Nissenson; Stuart M Sprague; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2010-03-03       Impact factor: 3.655

7.  Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria.

Authors:  Julius U Okoye; Ejikeme B Arodiwe; Ifeoma I Ulasi; Chinwuba K Ijoma; Obinna D Onodugo
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

8.  Estimation of the stability of parathyroid hormone when stored at -80 degrees C for a long period.

Authors:  Etienne Cavalier; Pierre Delanaye; Philippe Hubert; Jean-Marie Krzesinski; Jean-Paul Chapelle; Eric Rozet
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

Review 9.  Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.

Authors:  S N Salam; A Khwaja; M E Wilkie
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

10.  Health economic evaluation of peritoneal dialysis based on cost-effectiveness in Japan: a preliminary study.

Authors:  Tomoyuki Takura; Makoto Hiramatsu; Hidetomo Nakamoto; Takahiro Kuragano; Jun Minakuchi; Hironori Ishida; Masaaki Nakayama; Susumu Takahashi; Hideki Kawanishi
Journal:  Clinicoecon Outcomes Res       Date:  2019-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.